Blood Transfusion Diagnostics Global Forecast: Market to Scale Up to $6.86 Billion by 2030 at 6.4% CAGR
Uncover key drivers, emerging technologies, and competitive movements shaping the plate fin coil market from 2026–2035 with trusted insights from The Business Research Company
By how much is the Blood Transfusion Diagnostics Market expected to grow between 2026 and 2030?
The blood transfusion diagnostics market size has demonstrated significant expansion in recent years. This market is expected to increase from $4.96 billion in 2025 to $5.35 billion in 2026, reflecting a compound annual growth rate (CAGR) of 7.9%. The market’s past growth can be attributed to various factors, including the limited availability of advanced blood diagnostics instruments, a reliance on manual blood grouping methods, an increase in hospital blood transfusion procedures, the growing prevalence of transfusion-transmissible infections, and a lack of standardized reagents and kits.
The blood transfusion diagnostics market is projected to experience substantial expansion in the coming years. Its valuation is anticipated to reach $6.86 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.4%. This projected growth is driven by several factors, including the advancement of high-throughput automated blood screening systems, a growing need for nucleic acid amplification and rapid diagnostic tests, increased capital expenditure in blood banks and diagnostic laboratories, the integration of digital and AI-powered diagnostic tools, and the expansion of both plasma fractionation and research endeavors. Key trends expected during this period involve a heightened requirement for swift and precise blood typing, the wider implementation of automated blood processing systems, an increase in disease screening capacities, the expansion of plasma fractionation and diagnostic facilities, and a stronger emphasis on standardization and quality assurance.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2494&type=smp
Which Drivers Are Influencing Market Acceleration In The Blood Transfusion Diagnostics Market?
The increasing volume of surgical interventions is anticipated to propel the expansion of the blood transfusion diagnostics market. Surgical procedures involve medical operations conducted to address injuries, diseases, or disorders using manual or instrumental techniques. As the worldwide count of surgeries rises, there is a corresponding greater need for secure and compatible blood transfusions to replenish blood lost during these operations. Blood transfusion diagnostics play a vital role in screening and matching donor blood to prevent transfusion-related infections and complications, thereby ensuring patient safety and improving clinical outcomes. For instance, data from June 2024 by the American Society of Plastic Surgeons, a US-based non-profit organization, indicated that minimally invasive procedures saw a 7% increase in 2023, surpassing the growth rate of overall surgical procedures by 2%. Additionally, hand surgeries, covering conditions like carpal tunnel, arthritis, and trigger finger, reached a total of 207,887 procedures, marking a 2% rise from 2022. Consequently, the growing number of surgical procedures is acting as a key driver for the blood transfusion diagnostics market’s growth.
Blood Transfusion Diagnostics Market Driver: Rising Prevalence Of Blood-Related Diseases Fuels Blood Transfusion Diagnostics Market Growth
The escalating incidence of blood-related conditions is projected to boost the blood transfusion diagnostics market’s development. These diseases encompass a broad spectrum of disorders impacting the composition, function, or production of blood and its components, including various anemias, leukemia, and clotting disorders. Blood transfusion diagnostics are instrumental in the early detection and safe management of such conditions, guaranteeing compatible blood products and minimizing complication risks for patients. For example, in January 2023, figures from the American Cancer Society Inc., a US-based professional organization, reported approximately 59,610 new cases of leukemia (all types) and 23,710 deaths attributable to leukemia (all types). Moreover, around 20,380 new cases of acute myeloid leukemia (AML) were identified. Therefore, the expanding prevalence of blood-related diseases is a significant factor driving the growth of the blood transfusion diagnostics market.
What Segments Are Identified Within The Structure Of The Blood Transfusion Diagnostics Market?
The blood transfusion diagnostics market covered in this report is segmented –
1) By Type: Instruments And Kits, Reagents, Other Types
2) By Technology: Western Blot, ELISA, Nucleic Acid Amplification, Fluorescence Assay, Rapid Test
3) By Application: Blood Grouping, Disease Screening
4) By End User: Hospitals, Diagnostic Laboratories, Blood Banks, Plasma Fractionation Companies
Subsegments:
1) By Instruments And Kits: Blood Typing Instruments, Cross-Matching Kits, Blood Screening Instruments, Automated Blood Processing Systems
2) By Reagents: Antisera, Control Solutions, Blood Grouping Reagents, Enzymes And Other Reagents
3) By Other Types: Software Solutions, Consumables, Training And Support Services
How Are New Market Trends Shaping The Landscape Of The Blood Transfusion Diagnostics Market?
Leading companies in the blood transfusion diagnostics market are advancing technology, specifically innovations in transfusion technology, to improve the precision of blood typing, bolster patient safety, mitigate the threat of transfusion-transmitted infections, and enhance the efficiency of the overall transfusion process. Innovations in transfusion technology pertain to progress and enhancements in the techniques, tools, and procedures utilized in blood transfusion. As an illustration, in June 2024, Innobiochips Co. Ltd., a France-based biotechnology company, introduced Omnys, a significant innovation in transfusion, grouping, and blood testing. This state-of-the-art diagnostic platform is engineered to deliver swift and accurate blood typing, compatibility assessments, and pathogen identification. The innovative technology harnesses advanced biomarker identification and automation to optimize the transfusion process, thereby ensuring that blood products are safely matched to patients.
Which Key Players Are Driving Competition In The Blood Transfusion Diagnostics Market?
Major companies operating in the blood transfusion diagnostics market are Fresenius Kabi AG, Becton Dickinson and Company, Baxter International Inc., Medline Industries LP, Grifols SA, Terumo Corporation, Haemonetics Corporation, Sarstedt AG & Co KG, Cerus Corporation, Charter Medical Ltd, Kawasumi Laboratories Inc, Macopharma SA, GenesisBPS Inc, Werfen S.A, B Braun Melsungen AG, Immucor Inc, Kaneka Corporation, Nipro Medical Corporation, Teleflex Incorporated, Smiths Medical, HLL Lifecare Limited.
Access The Complete Report For Deeper Market Insights:
https://www.thebusinessresearchcompany.com/report/blood-transfusion-diagnostics-global-market-report
Which Region Is Projected To Lead The Blood Transfusion Diagnostics Market During The Forecast Period?
North America was the largest region in the blood transfusion diagnostics market in 2025. Western Europe was the second-largest region in the blood transfusion diagnostics industry. The regions covered in the blood transfusion diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Blood Transfusion Diagnostics Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=2494&type=smp
Browse Through More Reports Similar to the Global Blood Transfusion Diagnostics Market 2026, By The Business Research Company
Blood Group Typing Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/blood-group-typing-global-market-report
Dialysis Devices And Equipment Global Market Report 2026
Hemodialysis And Peritoneal Dialysis Global Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company